News & Events about Voyager Therapeutics Inc.
StockNews.com downgraded shares of Voyager Therapeutics (NASDAQ:VYGR Get Rating) from a buy rating to a hold rating in a research report sent to investors on Friday morning. Separately, Oppenheimer began coverage on shares of Voyager Therapeutics in a research report on Thursday, March 9th. They ...
Voyager Therapeutics, Inc. (NASDAQ:VYGR Get Rating) major shareholder Rock Ventures Iii L.P. Third sold 100,000 shares of the stock in a transaction that occurred on Friday, January 20th. The stock was sold at an average price of $9.15, for a total value of $915,000.00. Following the transaction, ...
Voyager Therapeutics, Inc. (NASDAQ:VYGR Get Rating) major shareholder Rock Ventures Iii L.P. Third sold 100,000 shares of the stock in a transaction that occurred on Friday, January 20th. The stock was sold at an average price of $9.15, for a total value of $915,000.00. Following the ...
Voyager Therapeutics, Inc. (NASDAQ:VYGR Get Rating) major shareholder Ecor1 Capital, Llc sold 456,000 shares of the companys stock in a transaction on Monday, January 9th. The stock was sold at an average price of $7.67, for a total transaction of $3,497,520.00. Following the ...